Vontobel Holding’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-4,531
Closed -$682K – 1269
2025
Q1
$682K Buy
4,531
+2,714
+149% +$455K ﹤0.01% 694
2024
Q4
$335K Buy
+1,817
New +$350K ﹤0.01% 893
2024
Q2
– Sell
-848
Closed -$230K – 1098
2024
Q1
$230K Sell
848
-44
-5% -$10.5K ﹤0.01% 977
2023
Q4
$211K Buy
+892
New +$175K ﹤0.01% 1008
2023
Q3
– Sell
-986
Closed -$207K – 1083
2023
Q2
$207K Buy
+986
New +$196K ﹤0.01% 1001
2023
Q1
– Sell
-3,349
Closed -$720K – 1083
2022
Q4
$720K Buy
+3,349
New +$731K 0.01% 659
2022
Q2
– Sell
-2,470
Closed -$716K – 1037
2022
Q1
$716K Sell
2,470
-392
-14% -$121K 0.01% 702
2021
Q4
$1.08M Buy
2,862
+1,585
+124% +$616K 0.01% 610
2021
Q3
$527K Buy
1,277
+375
+42% +$156K ﹤0.01% 779
2021
Q2
$335K Buy
+902
New +$301K ﹤0.01% 881

Other funds holding CRL

Vontobel Holding's CRL Position: Q2 2025 in Review

Vontobel Holding sold out of Charles River Laboratories (CRL) in Q2 2025, closing a stake of 4,531 shares — an estimated $682K sold.

Vontobel Holding first reported a position in CRL in Q2 2021 and held it in 10 quarters. The position peaked at $1.08M in Q4 2021. 519 funds tracked by Wall St. Rank hold CRL as of Q2 2025.

  • Vontobel Holding reported no remaining Charles River Laboratories position as of Q2 2025 after selling out during the quarter.
  • Vontobel Holding sold 4,531 Charles River Laboratories shares in Q2 2025, an estimated $682K.
  • Vontobel Holding first reported a position in Charles River Laboratories in Q2 2021 and held it in 10 quarters.
  • Vontobel Holding's Charles River Laboratories position peaked at $1.08M in Q4 2021.
  • 519 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2025.

Based on Vontobel Holding's 13F filing for Q2 2025, filed 23 Jul 2025.